Chromosome conformation capture (3C) technology is a pioneering methodology that allows in vivo genomic organization to be explored at a scale encompassing a few tens to a few hundred kilobase-pairs. Understanding the folding of the genome at this scale is particularly important in mammals where dispersed regulatory elements, like enhancers or insulators, are involved in gene regulation. 3C technology involves formaldehyde fixation of cells, followed by a polymerase chain reaction (PCR)-based analysis of the frequency with which pairs of selected DNA fragments are crosslinked in the population of cells. Accurate measurements of crosslinking frequencies require the best quantification techniques. We recently adapted the real-time TaqMan PCR technology to the analysis of 3C assays, resulting in a method that more accurately determines crosslinking frequencies than current semiquantitative 3C strategies that rely on measuring the intensity of ethidium bromide-stained PCR products separated by gel electrophoresis. Here, we provide a detailed protocol for this method, which we have named 3C-qPCR. Once preliminary controls and optimizations have been performed, the whole procedure (3C assays and quantitative analyses) can be completed in 7-9 days.
INTRODUCTION
Insight into genomic organization is key to understanding gene regulation in mammals. However, owing to technical limitations, we still have little idea about how the mammalian genome is structured in vivo at the scale at which long-range physical interactions between genes and dispersed regulatory elements most often take place (1-10 3 kbp). The recent development of the ''Tagging and recovery of associated proteins'' 1 and 3C (see ref.
2) assays allowed the very first glimpse into this crucial level of organization of the genome [3] [4] [5] . However, the RNA-TRAP technique, which is based on the targeting of peroxidase activity to nascent transcripts, is restricted to physical interactions occurring with actively transcribed genes, while 3C assays potentially allow identification of physical interactions between any chromatin segments. 3C technology is particularly suited to identify chromatin loops formed in genomic regions of up to several hundreds of kilobases in size. 5C technology 6, 7 offers a robust high-throughput alternative for this analysis, based on large-scale sequencing or microarray analysis. 5C is however more laborious to set up. To identify DNA segments that interact over distances larger than several hundreds of kilobases, we recommend using 4C technology [8] [9] [10] [11] , which allows for an unbiased genome-wide screen for DNA elements that interact with a genomic site of choice.
The principle of 3C technology 2 ( Fig. 1 ) is based on formaldehyde crosslinking of interacting chromatin segments, followed by restriction digestion and intramolecular ligation of crosslinked fragments. Ligation products are subsequently analyzed by PCR using primers specific for the restriction fragments of interest. The mere detection of a ligation product between two segments does not reveal much. To identify a chromatin loop between two segments, it needs to be demonstrated that they interact more frequently with each other than with neighboring DNA fragments. A meaningful 3C analysis therefore critically relies on the accurate quantification of the different ligation products, which in turn requires that measurements are taken when the DNA amplification reaction is in the linear range.
In traditional 3C experiments, a standard PCR protocol, which uses a standard number of PCR cycles and a standard amount of DNA template, is applied to the analysis of all different ligation products. Amounts are then estimated by measuring the intensity of ethidium bromide-stained PCR products separated by gel electrophoresis. This semiquantitative method is prone to provide inaccurate data, as measurements will not always be taken when the DNA amplification reaction is in the linear range.
The TaqMan quantitative PCR technology [12] [13] [14] provides more accurate measurements and was recently used to analyze higher order chromatin structure at the mouse HoxB1 (see ref. 10 ), a-globin 15 and b-globin loci 16 using the protocol described here. TaqMan technology makes use of a locus-specific oligodeoxynucleotide probe modified at its 5¢ and 3¢ ends by a fluorophore and a quencher, respectively. During the elongation step of the PCR, the 5¢-3¢ exonuclease activity of the Taq DNA polymerase 17 degrades the probe and releases the fluorophore from the quencher (Fig. 1) , thus generating a fluorescent signal that is quantified at each PCR cycle 12, 13 . The latter allows measurements to be always taken during the linear range of amplification. Quantifications correspond to a ''threshold cycle'' (Ct) that is determined as close as possible to the base of the exponential phase by defining a baseline to eliminate the background found in early cycles of amplification. Here we explain how TaqMan technology can be applied to the quantitative analysis of the ligation products generated by the 3C procedure. We refer to this strategy as 3C-qPCR. In addition, we provide a detailed step-by-step protocol for the preparation of 3C DNA templates prepared from mouse tissues that can subsequently be used for quantitative (or semiquantitative) PCR analysis. Modifications to the method presented below may be required to prepare 3C templates from other sources.
Experimental design
Preparations before 3C assays, as described below, are the most laborious and timeconsuming part of the procedure. It is also a critical part of the procedure, as both the resolution and sensitivity of the technique largely depend on its experimental design.
Restriction enzyme choice
The restriction enzyme should dissect the locus such that it allows for the separate analysis of the relevant regulatory elements (gene bodies, promoters, enhancers, insulators, etc.). Analyzing the topology of small loci (o10-20 kb) requires the use of frequently cutting restriction enzymes such as DpnII or NlaIII (4-base cutters). When analyzing larger loci, 6-base cutters such as EcoRI, BglII or HindIII can also be used. Enzymes that generate cohesive ends are recommended, as blunted ends do not allow efficient ligation (Step 13 of PROCE-DURE). Restriction enzymes that are sensitive to DNA methylation should not be used, as they can introduce a bias into the assay owing to differences in the digestion efficiency of the restriction sites analyzed. An additional digestion of the ligation products with a different restriction enzyme may optionally be performed for reliable quantification; this should help to minimize potential PCR biases owing to differences in template accessibility 15 (see Box 1). Obviously, the corresponding restriction site (EcoRI in the example in Box 1) should be absent from the PCR amplicons that will be used for ligation product quantification. Therefore, this additional restriction enzyme should be chosen when designing PCR primers used for quantifications. A prerequisite is thus to possess a reliable genomic sequence of the locus pertaining to the biological samples that will be studied.
TaqMan probe design
From the quantity of genomic DNA required to detect ligation products, we estimate that some locus-specific ligation events may occur in only 1/2,000 to 1/20,000 mammalian cells. Therefore, reliable quantification of ligation products is possible only if large amounts of DNA (i.e., many genome equivalents) are added to each PCR; we routinely use 50-200 ng of 3C template (B8 Â 10 4 to 3 Â 10 5 genome equivalents) per PCR. As such large amounts of DNA preclude the use of Syb R Green incorporation as a means to quantify PCR products 4 , the highly specific TaqMan chemistry is required for quantifications by real-time PCR. The 3C analysis quantifies ligation products generated by ligation of a ''constant fragment'' with candidate interacting fragments of the locus. Quantification of these ligation products requires a TaqMan probe and a ''constant primer'' (C) both located in the ''constant fragment'' , combined with a battery of ''test primers'' (T) designed in the candidate interacting fragments. For efficient amplification of ligation products, the amplicon needs to be small, and test primers therefore should be designed to hybridize as close as possible to, and preferably within 50 bp of, the restriction sites of interest. The TaqMan probe and the ''constant primer'' should also be designed as close as possible to the relevant restriction site and, importantly, they should hybridize to opposite strands of the ''constant fragment'' 16 . This configuration results in a fluorescent signal that is strictly specific to the amplification of the ligation product selected for analysis (see Fig. 1 ). As the TaqMan probe is designed to hybridize within the constant fragment, this probe can be used for quantification of all products ligated to the ''constant fragment'' . Further details on primer and probe design can be found in the REAGENT SETUP section.
Control template/primer efficiency A control template that contains all ligation products in equal amounts is used to optimize real-time PCRs and to establish the minimal amount of ligation product that can still be quantified in a reliable manner. For the PCR control template, we recommend the use of a single Bacterial Artificial Chromosome (BAC) clone covering the genome segment under study. Alternatively, a set of minimally overlapping BAC clones mixed in equimolar amounts could be used 18, 19 . This BAC is then cut with the restriction enzyme of choice (e.g., HindIII) and religated by T4 DNA ligase. A secondary restriction enzyme (e.g., EcoRI) can be used to linearize DNA circles, which may otherwise affect primer hybridization Step 1: interacting chromatin segments are crosslinked by a formaldehyde treatment; Step 2: DNA is digested by an appropriate restriction enzyme; and Step 3: crosslinked fragments undergo intramolecular ligation and give ligation products that will be quantified by qPCR. (b) TaqMan probe and qPCR primers design. The locations of the constant fragment (black segment) and candidate interacting fragments (red, blue, green and pink segments) are shown in the upper part of the figure. Restriction sites that will be used in the 3C assay are depicted as small vertical bars in blue. The relative positions of the TaqMan probe (Q-F) and test primers (black arrows T1-T4) that will be used for qPCR quantifications are also depicted. The TaqMan probe should be designed on the strand antisense to the ''Constant'' primer (black arrow C), but in the same restriction fragment, as depicted in the figure. During the elongation step of the PCR, the 5¢-3¢ exonuclease activity of the Taq DNA polymerase degrades the probe and releases the fluorophore from the quencher, thus generating a fluorescent signal that is strictly specific to the amplification of the relevant ligation products. T, test primer; F, fluorophore; Q, quencher. efficiency 20 . It is then necessary to make serial dilutions of this reaction to obtain standard curves that cover the same range of ligation product concentrations as those that will be obtained in the 3C samples. To mimic 3C sample conditions, the final DNA concentration in these dilutions is adjusted to the amount of DNA used in the 3C samples (see Step 38 of PROCEDURE). Thus, depending on the amount of 3C sample used, these dilutions are performed on a 50-200 ng genomic DNA solution.
Experimental controls
Several controls need to be performed on each 3C sample to obtain meaningful data. Sample purity (Steps 35-37) and digestion efficiency (Box 2) should be carefully assessed, as they may impair accurate quantifications. Finally, the level of random collisions needs to be assessed carefully to distinguish between relatively frequent but nonfunctional interactions from physiologically relevant interactions (see the ANTICIPATED RESULTS section). To correct for differences in crosslinking and digestion efficiencies between samples, 3C-qPCR data are normalized toward a set of ''control interaction frequencies'' . For this purpose, we routinely use the locus of the ERCC3 gene (excision repair cross-complementing rodent repair deficiency, complementation group 3), a ubiquitously expressed gene. As this gene is expressed at very similar levels in all mouse tissues, higher order chromatin architecture at this locus is assumed to be identical and can be used for normalization of 3C-qPCR data (for primer sequences used in combination with HindIII, see Splinter et al. 16 ). 
BOX 1 | OPTIONAL COMPLEMENTARY DIGESTION TIMING 3-4 H
This additional digestion of religated DNA can help to minimize potential PCR biases that may result from limited template accessibility 20 . We have used EcoRI as an example below, but any suitable restriction enzyme and buffer can be used (see the Experimental design section). (i) To the sample from Step 34, add 28 ml of dH 2 O and 20 ml of 1Â EcoRI buffer (commercial 10Â buffer for EcoRI (or any other selected restriction enzyme) diluted in water).
(ii) Place the sample in a 1.5 ml tube and add 2 ml of 50 U ml À1 EcoRI enzyme (100 U final). 
BOX 2 | DETERMINATION OF DIGESTION EFFICIENCY TIMING 7-8 H
Digestion efficiencies should be carefully assessed for each restriction site involved in the analysis. Indeed, a twofold drop in digestion efficiency of a given site causes a twofold reduction in the available amount of a given restriction end, which would affect the number of ligation products it can form. Therefore, digestion efficiencies should be in the same range for each of the sites of interest. (i) Add 500 ml of 1Â PK buffer and 1 ml of 20 mg ml À1 PK (20 mg final) to the control aliquots saved in Steps 12 (UND) and 14 (D).
(ii) Incubate for 30 min at 65 1C (or overnight at 65 1C if performed in parallel to Steps 22-34). (iii) Equilibrate for a few minutes at 37 1C, then add 1 ml of 1 mg ml À1 RNase A (1 mg final) and incubate for 2 h at 37 1C. (xiii) Perform real-time PCR quantifications (Syb R Green) on both samples (UND and D) using the qPCR conditions detailed in Steps 38A(ii) and (iii) of the main procedure. To check digestion efficiencies, use primer sets that amplify across each restriction site of interest (R); these should be designed as outlined in the REAGENT SETUP section. To correct for differences in the amount of template added to the PCR, also PCR-amplify control regions not containing the restriction sites of interest (use the ''internal'' primers used for loading adjustments, Step 38). (xiv) Use the cycle thresholds (Ct values, i.e., the number of PCR cycles required to generate a threshold amount of PCR product) to calculate the restriction efficiency according to the following formula: . Ribonuclease A (RNase A), 1 mg ml À1 . Proteinase K (PK), 10 mg ml À1 . PK buffer (5 mM EDTA, pH 8.0; 10 mM Tris-HCl, pH 8.0;
0.5% SDS)
. Control PCR primers for assessing DNA digestion efficiency, user-specific (see REAGENT SETUP) . Forward and reverse ''internal'' primers for loading adjustments, user-specific (see REAGENT SETUP) . Constant and test PCR primers for quantifying 3C reaction, user-specific (see REAGENT SETUP) . PCR primers for determining digestion efficiency, user-specific (see REAGENT SETUP) . PCR primers for determining control interaction frequencies, user-specific (see REAGENT SETUP) . TaqMan . 40 mm cell strainer (352340 Falcon).
REAGENT SETUP Lysis of cells The choice of lysis buffer depends on the tissue or cell type used. For most tissues, the lysis buffer described above will be sufficient. If cells are not properly lysed, a different lysis buffer containing NP-40 can be used (10 mM Tris-HCl, pH 7.5; 10 mM NaCl; 0.2% NP-40; 1Â complete protease inhibitor (11836145001 Roche)). If this is not sufficient, an additional douncing step can be included as described in troubleshooting Step 5. Staining cells with Methylgrün-Pyronin and viewing them under a light microscope can confirm cell lysis. PCR primer design All PCR primers used in this protocol should be typically 20-22-mers with a T m in the range 55-65 1C with a 2 1C maximum difference between all primers used in a single experiment. Primers could be designed using software available on the internet (e.g., http://frodo.wi.mit.edu/cgi-bin/ primer3/primer3_www.cgi). PCR primers used for analyzing digestion efficiency or the 3C assays should be designed close (within 50 bp) to the restriction site used for the 3C assays. TaqMan probe design The annealing temperature of the probe should be 8-10 1C higher than that of the PCR amplification primers. The probe should be 20-30 nucleotides long and contain more C than G residues. Avoid G in the most 5¢ position (which could quench the fluorescent reporter), and stretches of four consecutive identical nucleotides (particularly G). We have used 5¢FAM-3¢BHQ R and 5¢FAM-3¢TAMRA probes 12, 13 . TaqMan probes are dissolved in TE pH 8.0 and stored at À20 1C as 1.5 mM aliquots. 3| Transfer the reaction tubes to ice and add 1.425 ml of 1 M glycine (ice cold) to quench the crosslinking reaction. m CRITICAL STEP Glycine will inactivate the excess formaldehyde that did not react with the biological sample. The glycine concentration described here is sufficient for most biological samples. However, if the sample is low in free amino groups, quenching may not be complete; in this case, the glycine concentration should be increased before proceeding immediately to Step 4.
4| Spin for 8 min at 225g at 4 1C and carefully remove all the supernatant.
Cell lysis TIMING 20-25 min 5| Take up the pellet in 5 ml cold lysis buffer and incubate for 10 min on ice. m CRITICAL STEP It is important to obtain a homogeneous preparation of nuclei, which may be facilitated by gently pipetting the mixture up and down. Depending on the cell type, more stringent lysis buffers may be needed to prepare nuclei (see REAGENT SETUP).
? TROUBLESHOOTING 6| Centrifuge for 5 min at 400g at 4 1C and remove the supernatant.
? TROUBLESHOOTING ' PAUSE POINT The pelleted nuclei can be frozen in liquid nitrogen and stored at -80 1C for several months.
Digestion TIMING 18-20 h 7| Take up the nuclei in 0.5 ml of 1.2Â restriction enzyme buffer and transfer to a safe-lock tube.
8|
Place the tube at 37 1C and add 7.5 ml of 20% (w/v) SDS (final: 0.3% SDS).
9|
Incubate for 1 h at 37 1C while shaking at 900 r.p.m. ? TROUBLESHOOTING 10| Add 50 ml of 20% (v/v) Triton X-100 (final: 2% Triton X-100).
11| Incubate for 1 h at 37 1C while shaking at 900 r.p.m.
12| Take a 5 ml aliquot of the sample and label as an undigested genomic DNA control (UND). This sample may be stored at À20 1C until it is needed to determine the digestion efficiency (see Step 14 and Box 2).
13| Add 400 U of the selected restriction enzyme to the remaining sample and incubate overnight at 37 1C while shaking at 900 r.p.m. 16| Incubate for 20-25 min at 65 1C; shake at 900 r.p.m.
17|
Transfer the digested nuclei to a 50 ml falcon tube.
18| Add 6.125 ml of 1.15Â ligation buffer.
19| Add 375 ml of 20% (v/v) Triton X-100 (final 1% Triton X-100). 22| Add 30 ml of 10 mg ml À1 PK (300 mg final).
23|
Incubate at 65 1C overnight to de-crosslink the sample.
DNA purification TIMING 5-6 h 24| Add 30 ml of 10 mg ml À1 RNase (300 mg final).
25| Incubate for 30-45 min at 37 1C.
26| Add 7 ml of phenol-chloroform and mix vigorously.
27| Centrifuge for 15 min at 2,200g at room temperature (18-22 1C).
? TROUBLESHOOTING 28| Transfer the supernatant into a new 50 ml tube and add 7 ml of distilled water, 1.5 ml of 2 M sodium acetate pH 5.6 followed by 35 ml of ethanol. m CRITICAL STEP Increasing the volume before precipitation will dilute the DTT present in the ligation buffer and prevent it from precipitating (white pellet).
29|
Mix and place at À801 C for approximately 1 h.
30| Centrifuge for 45 min at 2,200g at 4 1C.
31|
Remove the supernatant and add 10 ml of 70% (v/v) ethanol.
32| Centrifuge for 15 min at 2,200g at 4 1C.
33| Remove the supernatant and briefly dry the pellet at room temperature (18-22 1C).
34| Dissolve the DNA pellet in 150 ml of 10 mM Tris pH 7.5. The 3C template is now ready for qPCR analysis. If an additional digestion step is required to maximize template accessibility, follow the procedure in Box 1 before continuing with
Step 35 and qPCR analysis. ? TROUBLESHOOTING ' PAUSE POINT 3C template may be kept at À20 1C for several months.
Assessment of sample purity TIMING 2-4 h
35| Dilute an aliquot of the 3C sample (from Step 34) two-to tenfold. Add genomic DNA to the diluted reaction samples such that the total amount of DNA in each reaction is constant and between 50 and 200 ng.
36| Set up 10 ml qPCRs as detailed in the table below. Any 3C test primer can be used. Perform a standard curve in the same run using serial dilutions of the control template (see Experimental design) according to the instructions of the manufacturer of the qPCR apparatus.
Stock component Amount Final
0.5 ml (5 pmol) 0.5 mM Constant primer (10 mM) 0.5 ml (5 pmol) 0.5 mM QuantiTech Probe PCR Master Mix 5 ml TaqMan probe (1.5 mM)
1 ml (1.5 pmol) 0.15 mM 3C sample (from Step 35) 1 ml 37| Run the qPCR using the conditions tabulated below. Check that real-time PCR quantifications are reduced according to the dilution factors (see Example in the ANTICIPATED RESULTS section). If this is not the case, sample purity is not appropriate and the sample should be discarded. 1 ml (10 pmol) 0.5 mM Reverse internal primer (10 mM) 1 ml (10 pmol) 0.5 mM qPCR mix 14 2 ml 50Â dilution of 3C sample (Step 38A(i)) 2 ml (iii) Carry out qPCR using the conditions tabulated below:
Cycle number Denature Anneal and extend The relative level of each ligation product (fragments À1 to 8 and 17 to 20) has been plotted according to its distance (in kb) from the Igf2 promoter P0 (see map below graphs). The ''constant'' primer and the TaqMan probe were designed as described in Figure 1 (also see PCR primer design in the REAGENT SETUP section) in a BamHI fragment (fragment 21) containing the H19 endodermic enhancers (see Tables 2 and 5) . Two independent 3C-qPCR experiments (A1, blue curve; A2, pink curve) were performed on the same biological samples. The data were normalized either to a Gapdh loading control (a) or to Pdhb ''control interaction frequencies'' (b). Below the graphs, the BamHI restriction fragments are indicated. BamHI fragments are numbered from fragment À1 to 21. Arrows P0-P3 indicate the four Igf2 promoters. The locations of the imprinting-control region (ICR, white rectangle in fragment 18), Igf2 and H19 genes (black rectangle in fragment 19), the endodermic enhancers (black circles in fragment 21), the matrix attachment region 3 (MAR3, white rectangle in fragment 8) and the differentially methylated region 1 (DMR1, white rectangle in fragment 2) are also indicated. (ii) Run corresponding dilutions of sample and reference DNA side by side on an agarose gel (0.8-2%); the ligated 3C samples (and the undigested genomic reference sample) will run as a single high-molecular-weight band. (iii) Quantify and compare the amount of DNA between the ligated 3C samples and the reference sample by measuring ethidium bromide incorporation using a Typhoon 9200 imager (GE Healthcare). Processed images are analyzed using ImageQuant software (GE Healthcare) to determine the DNA concentration.
39| Adjust the original 3C assays (from Step 34) with H 2 O to 50 ng ml À1 ±10% and optionally verify this concentration by repeating the measurements as described in Step 38.
Real-time PCR quantifications of ligation products TIMING 2-4 days (2-3 h per run; number of runs depends on the number of primer pairs and 3C samples to be analyzed) 40| Perform TaqMan real-time PCR quantifications of ligation products on 1 ml (containing B50 ng of DNA) of the ''adjusted'' 3C samples (from Step 39). Use the reaction conditions described in Step 36.
41|
For each ligation product, run the qPCR using the PCR parameters tabulated in Step 37. Perform standard curves in each run using serial dilutions of the control template (see Experimental design) according to the instructions of the manufacturer of the qPCR apparatus. Analyze data as described in the ANTICIPATED RESULTS section. m CRITICAL STEP 3C-qPCR data have to be normalized toward a ''loading control'' (''internal'' primers located in the gapdh gene in the example experiment below) and a set of ''control interaction frequencies'' . This latter control should be performed on each 3C assay using a pair of test/constant primer localized in a locus that contains a ubiquitously expressed gene. For this purpose, we routinely use primer pairs within the locus of the ERCC3 (see ref. 16) or PDHB genes (see Example in the ANTICIPATED RESULTS section). ? TROUBLESHOOTING
TIMING
Step 1 Step When using an enzyme other than HindIII, check that the composition of the recommended restriction buffer is not too different from the one used in the present protocol. Optimizing digestion percentages can also be done by varying the SDS/Triton X-100 amounts before digestion and
ANTICIPATED RESULTS Data analysis
As recently stressed elsewhere 18 , for each 3C sample, the level of random collisions needs to be assessed carefully to distinguish relatively frequent but nonfunctional interactions from physiologically relevant interactions. The background of random collisions can be estimated by determining the interaction frequencies between sites separated by increasing genomic distances (see Example of experiment). As mentioned previously, ''a specific interaction is detected when a local peak in interaction frequency is observed'' 18 . Using the 3C protocol to simply look for an interaction between two sites (e.g., promoter to enhancer) with just a few primer sets can easily result in misinterpretation of the data. However, some parameters-like the size of the restriction fragments-may influence the quantification of the ligation products 4 and create ''artifactual local peaks'' . Therefore, the comparison of relative crosslinking frequencies between two different samples is the best indication of physiologically relevant interactions.
Example of experiment 3C-qPCR was first validated by Splinter et al. 16 at the mouse b-globin locus. To further validate the 3C-qPCR protocol, we analyzed the enhancers/promoter interaction at the imprinted H19 locus on mouse chromosome 7, which is a mammalian locus recently analyzed by 3C assays using the standard procedure 21, 22 . We prepared nuclei from liver samples from 7-day-old mice (when Igf2 and H19 are highly expressed) 23 and proceeded until Step 34 of the 3C protocol as described above using BamHI 
BamHI fragment number
Forward primer sequence Constant primer À1  aatgaccaccagatgtcaagc  C3  2  ctgctccgtgtgagttcctt  C2  3  aggaccgcaaatcagacaag  C1  4  ctgcgtttgtttctccaggt  C3  7  gtggcaaggaaagtgaagga  C1  8  ggcagctcacatacaactcc  C1  17  ccagagcaggatgtgagagg  C2  18  ggcgggagacatagaaactgc  C1  19  gcagggttgccagtaaagac  C1  20 ccttgtcgtagaagccgtctg C1
Three ''constant primers'' (C1, C2 and C3) were designed as described in Figure 1 (also see the REAGENT SETUP section). These three primers are all located within a 35 bp sequence located 129-94 bp upstream of the 3¢ BamHI site of fragment 21. Their sequences are as follows (5¢ to 3¢): C1, aatgtggggagacaaacagc; C2, cccaaacgcttgaccctat; and C3, tgaccctatgcctggaatgt. For each ligation product, the ''constant primer'' giving the best amplification efficiency was used as indicated in the table. The ''ligation product-specific primers'' (''forward primers'') were designed upstream of the 3¢ BamHI site of each restriction fragment (fragments 1-20) (see Fig. 1 ). Their sequences are given in the table. All amplifications were performed as described in the PROCEDURE section (Steps 36 and 37). The sequence of the TaqMan probe used is as follows: 5¢FAM-cccaaccagggtcttcacggg-3¢BHQ R . This probe is located 56 bp upstream of the 3¢ BamHI site of fragment 21 (see Fig. 2 ). Loading controls (
Step 38) were performed using the following Gapdh primers (''internal'' primers, see the REAGENT SETUP section): forward primer (5¢ to 3¢): acagtccatgccatcactgcc; reverse primer (5¢ to 3¢): gcctgcttcaccaccttcttg.
by using 1% instead of 2% formaldehyde (Step 2 Step Problem Solution (
Step 13) and EcoRI (Box 1) restriction enzymes. Sample purity was then assessed on aliquots of three independent 3C assays (A1, A2 and X) as described above (Steps 35-37) using TaqMan PCR with a constant primer located into the fragment containing the H19 enhancers and test primer 20 (see Fig. 2 and Table 2 for primer sequences). The results of this purity control are given in Table 3 . The values correspond to the quantifications of the ligation product formed between fragment 20 and the constant fragment (C). These values are calculated using the parameters of the standard curve (b: intercept; a: slope) as follows: value¼10 (CtÀb)/a . One 3C assay (X) was discarded from the analysis because impurities impaired faithful quantifications (see Table 3 ). The purity of two other 3C samples (A1 and A2) was appropriate and we proceeded with loading adjustments (Step 38), as shown in Table 4 . SYBR Green quantifications were performed on an aliquot of a 50Â dilution of these 3C samples as described in
Step 38A. Once the original 3C samples had been appropriately diluted to 50 ng ml À1 (i.e., dilution factor of 5 for sample A1 or 9 for sample A2), we verified their concentration on an aliquot of a 50Â dilution of these adjusted samples (Step 39). Standard curves were obtained using serial dilutions of a reference sample (see Step 38A), giving a value of 1 for the 1 ng ml À1 point. The values were obtained using the ''internal'' primer set (here we used primers located in the Gapdh gene; see Table 2 for primer sequence). These values are calculated using the parameters of the standard curve (b: intercept; a: slope) as follows: value¼10 (CtÀb)/a .
Digestion efficiency was controlled as described in Box 2 (data not shown; for primer sequences see Table 5 ). Quantifications of ligation products were then performed using real-time PCR with a TaqMan probe designed in the fragment that contains the H19 enhancers (fragment 21; Fig. 2 ; for primer sequences, see Table 2 ). These enhancers are endoderm specific and are necessary for both Igf2 and H19 gene expression 24 . As shown in Figure 2a (loading control normalization) as well as in Figure 2b (normalization to control interaction frequencies, right graphs), for each 3C sample analyzed (A1 and A2), a local interaction peak is found with the restriction fragment that contains the H19 promoter (fragment 19). Raw data from this experiment are given in Table 6 as an example of data analysis. Step 40
Proceed with
Step 40 Ligation products obtained with fragments 17, 18, 19 and 20 (that encompass the H19 gene and promoter) were quantified from the A1 and A2 3C samples (from 7-day-old mouse livers) as described in Steps 40 and 41 (qPCR run no. 3, 4, 5 and 6/7 respectively). A ''loading control'' (''internal primers'' located in the gapdh gene) and a set of ''control interaction frequencies'' (PDHB primers) were performed (qPCR run no. 1 and 2 respectively) (for primer sequences see Table 2 ). For each fragment, we performed a triplicate quantification (Ct1, Ct2, Ct3), we then calculated the mean Ct. However, some of the triplicates (Ct in parentheses) have not been taken into account when calculating the mean Ct because they deviate from two other quantifications. The final value was calculated using the parameters of the standard curve (b: intercept; a: slope) as follows: value¼10 (Ct-b)/a . These values were finally normalized either to gapdh (loading control) (see Fig. 2a ) or Pdhb (control interaction frequency) (see Fig. 2b ). For fragment 20 (qPCR run no 6/7) two standard curves are given because the A1 and A2 samples were analyzed in two separate runs.
In the upstream part of the locus, we found that the H19 enhancers contact the sequences containing the differentially methylated region 1 (DMR1, fragment 2) (Fig. 2a,b, left graphs) . These results confirm the recently described data 21 and thus further validate the 3C-qPCR methodology.
